Corticosteroids alone

PreclinicalSmall molecule

Corticosteroids alone is one of 10 small molecule programs targeting Pulmonary Fibrosis. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Pulmonary FibrosisActive, not recruiting

Pulmonary FibrosisPreclinical

Active, not recruiting

Competition

Competitive Landscape

12 competitors in Pulmonary Fibrosis

#DrugCompanyPhaseTrials

Colcrys

Jazz Pharmaceuticals

Approved

1 2

Remodulin

United Therapeutics

Approved

—3

Pomalyst

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Approved

—4

Cytoxan

BBaxter Healthcare Corporation

Approved

—5

Acetadote

AArbor Pharmaceuticals, Inc.

Ofev

2 7

BMS-986278

Bristol-Myers Squibb

Phase 3

2 8

CBP8

MMassachusetts General Hospital

Phase 2

1 9

HRS-9813

Guangdong Hengrui Pharmaceutical Co., Ltd

Phase 2

2 10

Corticosteroids alone

MMansoura University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2028

Phase 3Not yet recruiting

Venous Thrombosis

NCT06780462

Clinical

Trials by Indication[1]

Pulmonary Fibrosis1 trial

Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis

Completed·MMansoura University··NCT05648734·200 enrolled

Venous thrombosis1 trial

Randomized Controlled Multicenter Study Comparing Steroid Therapy Plus Anticoagulants to Steroid Therapy Alone in Deep Venous Thrombosis of Behçet's Syndrome

Not yet recruiting·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT06780462·134 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Corticosteroids alone. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Corticosteroids alone compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Corticosteroids alone. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Mansoura University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMansoura University

Corticosteroids alone

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2028

Trials by Indication[1]

Pulmonary Fibrosis1 trial

Venous thrombosis1 trial

References

Drug Info

Quick Facts

Related News